The Association between Dynamic Changes of Metabolic Syndrome and Type 2 Diabetes Mellitus (T2DM) or Cardiovascular Disease (CVD)

被引：0
|
作者：
Yang, C. [1 ,2 ]
Guo, Z. R. [1 ]
Hu, X. S.
Zhou, Z. Y. [3 ]
Wu, M.
Yu, H. [1 ]
Zhang, L. J. [1 ]
Luo, W. S. [1 ]
Liu, J. C. [1 ]
机构：
[1] Soochow Univ, Sch Radiol Med & Publ Hlth, Suzhou 215123, Peoples R China
[2] Ctr Dis Control, Suzhou, Peoples R China
[3] Ctr Dis Control, Changshu, Peoples R China
来源：
CARDIOLOGY | 2010年 / 117卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：119 / 120
页数：2
相关论文
共 50 条
  • [31] Metabolic syndrome and risk of CVD and type 2 diabetes mellitus
    Wilson, PW
    D'Agostino, RB
    Sullivan, L
    Meigs, J
    [J]. CIRCULATION, 2003, 107 (07) : E7004 - E7004
  • [32] The association between race/ethnicity and adverse perinatal outcomes among women with diabetes mellitus type 2 (T2DM)
    Niu, Brenda
    Frias, Antonio
    Nguyen, Brian
    Snowden, Jonathan
    Cheng, Yvonne
    Caughey, Aaron
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 210 (01) : S147 - S147
  • [33] Association between family history of Type 2 diabetes and cardiovascular disease and the metabolic syndrome
    Dunkley, A. J.
    Davies, M. J.
    Taub, N.
    Khunti, K.
    [J]. DIABETIC MEDICINE, 2007, 24 : 54 - 54
  • [34] Association of MTHFR C677T polymorphism and type 2 diabetes mellitus (T2DM) susceptibility
    Meng, Yanzi
    Liu, Xiaoling
    Ma, Kai
    Zhang, Lili
    Lu, Mao
    Zhao, Minsu
    Guan, Min-Xin
    Qin, Guijun
    [J]. MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (12):
  • [35] Association of Dietary Intake of Phosphorus with Obesity in Japanese Patients with Type 2 Diabetes Mellitus (T2DM)
    Hatta, Mariko
    Fujihara, Kazuya
    Matsubayashi, Yasuhiro
    Takeda, Yasunaga
    Nedachi, Rina
    Ishii, Dai
    Horikawa, Chika
    Kato, Mitsutoshi
    Maegawa, Hiroshi
    Sone, Hirohito
    [J]. DIABETES, 2019, 68
  • [36] Dynamic Channeling among Initiators of a Recently Marketed Medication for Type 2 Diabetes Mellitus (T2DM)
    Patorno, Elisabetta
    Gopalakrishnan, Chandrasekar
    Zorina, Olesya I.
    Schneeweiss, Sebastian
    Bartels, Dorothee B.
    Liu, Jun
    Seeger, John D.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 565 - 566
  • [37] BURDEN OF CARDIOVASCULAR DISEASE AND CARDIOVASCULAR (CV) RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM): AN ANALYSIS OF A US HEALTH INSURANCE DATABASE
    Meyers, J.
    Hoog, M.
    Mody, R.
    Yu, M.
    Hasenour, C.
    Davis, K. L.
    [J]. VALUE IN HEALTH, 2020, 23 : S115 - S115
  • [38] Does obesity cause type 2 diabetes mellitus (T2DM)? Or is it the opposite?
    Malone, John I.
    Hansen, Barbara C.
    [J]. PEDIATRIC DIABETES, 2019, 20 (01) : 5 - 9
  • [39] Altered bile salt metabolism in type 2 diabetes mellitus (T2DM)
    Brufau, Gemma
    Kuipers, Folkert
    Prado, Kris
    Abbey, Stacey
    Jones, Michael
    Schwartz, Sherwyn
    Stellaard, Frans
    Murphy, Elizabeth
    [J]. DIABETES, 2008, 57 : A435 - A435
  • [40] Bayesian nonparametric comorbidity analysis of type 2 diabetes mellitus (T2DM)
    De la Torre, Adrian Martinez
    Perez-Cruz, Fernando
    Weiler, Stefan
    Burden, Andrea
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 503 - 504
12345